^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Kidney Cancer |
| Drug: | Avastin (bevacizumab) (VEGF-A inhibitor) + erlotinib (EGFR inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Kidney Cancer: Principles for systemic therapy for relapse or stage IV disease...Useful in Certain Circumstances...Bevacizumab + erlotinib
